# Aurinia Pharmaceuticals Inc.: Form 8-K, filed Apr 3, 2026

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2026-04-03
- Accepted by EDGAR: Apr 3, 2026, 16:56 ET
- Period: 2026-03-30
- Accession: 0001600620-26-000035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062026000035/auph-20260330.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062026000035/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062026000035/auph-20260330.htm

Filed Apr 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001600620-26-000035. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.